ABSTRACT
Recent synthetic and theoretical investigations of organometallic compounds containing the CpCr(NO) fragment have shown an interdependence of the electronic nature of ancillary ligands and the stability of a given Cr oxidation state. Understanding the correlation between ligand pi-bonding properties and the nature of the metal-based frontier orbitals permits the rationalization of observed reactivity patterns, and the identification and preparation of new classes of target molecules.
ABSTRACT
Thermal activation of CpW(NO)(CH(2)CMe(3))(2) (1) in neat hydrocarbon solutions transiently generates the neopentylidene complex, CpW(NO)(=CHCMe(3)) (A), which subsequently activates solvent C-H bonds. For example, the thermolysis of 1 in tetramethylsilane and perdeuteriotetramethylsilane results in the clean formation of CpW(NO)(CH(2)CMe(3))(CH(2)SiMe(3)) (2) and CpW(NO)(CHDCMe(3))[CD(2)Si(CD(3))(3)] (2-d(12)), respectively, in virtually quantitative yields. The neopentylidene intermediate A can be trapped by PMe(3) to obtain CpW(NO)(=CHCMe(3))(PMe(3)) in two isomeric forms (4a-b), and in benzene, 1 cleanly forms the phenyl complex CpW(NO)(CH(2)CMe(3))(C(6)H(5)) (5). Kinetic and mechanistic studies indicate that the C-H activation chemistry derived from 1 proceeds through two distinct steps, namely, (1) rate-determining intramolecular alpha-H elimination of neopentane from 1 to form A and (2) 1,2-cis addition of a substrate C-H bond across the W=C linkage in A. The thermolysis of 1 in cyclohexane in the presence of PMe(3) yields 4a-b as well as the olefin complex CpW(NO)(eta(2)-cyclohexene)(PMe(3)) (6). In contrast, methylcyclohexane and ethylcyclohexane afford principally the allyl hydride complexes CpW(NO)(eta(3)-C(7)H(11))(H) (7a-b) and CpW(NO)(eta(3)-C(8)H(13))(H) (8a-b), respectively, under identical experimental conditions. The thermolysis of 1 in toluene affords a surprisingly complex mixture of six products. The two major products are the neopentyl aryl complexes, CpW(NO)(CH(2)CMe(3))(C(6)H(4)-3-Me) (9a) and CpW(NO)(CH(2)CMe(3))(C(6)H(4)-4-Me) (9b), in approximately 47 and 33% yields. Of the other four products, one is the aryl isomer of 9a-b, namely, CpW(NO)(CH(2)CMe(3))(C(6)H(4)-2-Me) (9c) ( approximately 1%). The remaining three products all arise from the incorporation of two molecules of toluene; namely, CpW(NO)(CH(2)C(6)H(5))(C(6)H(4)-3-Me) (11a; approximately 12%), CpW(NO)(CH(2)C(6)H(5))(C(6)H(4)-4-Me) (11b; approximately 6%), and CpW(NO)(CH(2)C(6)H(5))(2) (10; approximately 1%). It has been demonstrated that the formation of complexes 10 and 11a-b involves the transient formation of CpW(NO)(CH(2)CMe(3))(CH(2)C(6)H(5)) (12), the product of toluene activation at the methyl position, which reductively eliminates neopentane to generate the C-H activating benzylidene complex CpW(NO)(=CHC(6)H(5)) (B). Consistently, the thermolysis of independently prepared 12 in benzene and benzene-d(6) affords CpW(NO)(CH(2)C(6)H(5))(C(6)H(5)) (13) and CpW(NO)(CHDC(6)H(5))(C(6)D(5)) (13-d(6)), respectively, in addition to free neopentane. Intermediate B can also be trapped by PMe(3) to obtain the adducts CpW(NO)(=CHC(6)H(5))(PMe(3)) (14a-b) in two rotameric forms. From their reactions with toluene, it can be deduced that both alkylidene intermediates A and B exhibit a preference for activating the stronger aryl sp(2) C-H bonds. The C-H activating ability of B also encompasses aliphatic substrates as well as it reacts with tetramethylsilane and cyclohexanes in a manner similar to that summarized above for A. All new complexes have been characterized by conventional spectroscopic methods, and the solid-state molecular structures of 4a, 6, 7a, 8a, and 14a have been established by X-ray diffraction methods.
ABSTRACT
Nitrovasodilators cause endothelium-independent relaxation of blood vessels by generating nitric oxide (NO). We examined the relaxation and depressor effects of two organotransition-metal nitrosyl complexes, CpCr(NO)2Cl and CpMo(NO)2Cl, relative to those of the prototypal nitrovasodilators, nitroglycerin, and sodium nitroprusside (SNP), in phenylephrine-preconstricted aortic rings and conscious, unrestrained rats. CpCr(NO)2Cl, CpMo(NO)2Cl, nitroglycerin and SNP caused dose-dependent relaxation of aortic rings at maximal responses (Emax) of -118+/-4, -113+/-4, -104+/-1, and -128+/-5% and EC50 of 0.14+/-0.04, 22+/-4, 1.23+/-0.65, and 0.063+/-0.013 microM, respectively. The dose-response curve of CpCr(NO)2Cl was displaced to the right by hemoglobin, as well as methylene blue, showing involvement of the NO/cGMP pathway. Unlike nitroglycerin, preexposure for 1 h to CpCr(NO)2Cl did not alter subsequent relaxation response to the compound. Intravenous bolus injections of CpCr(NO)2Cl, CpMo(NO)2Cl, nitroglycerin, and SNP caused dose-dependent decreases in MAP with Emax of -42+/-2, -51+/-8, -56+/-6, and -58+/-2 mm Hg and EC50 of 0.041+/-0.010, 13+/-4, 1.6+/-0.4, and 0.037+/-0.004 micromol/kg, respectively. These results show that CpCr(NO)2Cl and CpMo(NO)2Cl are efficacious nitrovasodilators in vitro and in vivo.
Subject(s)
Nitric Oxide Donors/pharmacology , Organometallic Compounds/pharmacology , Vasodilator Agents/pharmacology , Animals , Drug Tolerance , Endothelium, Vascular/physiology , Enzyme Inhibitors/pharmacology , Hemoglobins/pharmacology , In Vitro Techniques , Male , Methylene Blue/pharmacology , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type III , Nitroglycerin/pharmacology , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Rats , Rats, Sprague-DawleyABSTRACT
Treatment of [Cp*Mo(NO)Cl(mu-Cl)](2) with magnesium (Me(2)Mg.dioxane, MeMgCl) or aluminum (Me(3)Al) methylating reagents affords the known compound [Cp*Mo(NO)Me(mu-Cl)](2) (1). Similar treatment of the dichloro precursor with MeLi in ethereal solvents generates an equimolar mixture of 1 and the trimethyl "ate" complex, Cp*MoMe(3)(NO-Li(OEt(2)(n)), (2-Et(2)O). Reaction of 2-Et(2)O with a source of [Me](+) forms Cp*MoMe(3)(=N-OMe)(3), a rare terminal alkoxylimido complex. Metathesis of the chloro ligands of [Cp*Mo(NO)Cl(mu-Cl)](2) by MeLi in toluene at low temperatures produces the target dimethyl complex, Cp*Mo(NO)Me(2) (4), in 75% isolated yield. In solution, 4 is predominantly a monomeric species, whereas in the solid state it adopts a dimeric or oligomeric structure containing isonitrosyl bridges as indicated by IR and (15)N/(13)C NMR spectroscopies. Hydrolysis of 4 affords meso- and rac-[Cp*Mo(NO)Me](2)(mu-O) (5), and the reactions of 4 with a range of Lewis bases, L, to form the 18e adducts Cp*Mo(NO)(L)Me(2) (e.g., Cp*Mo(NO)(PMe(3))Me(2) (7)), have established it to be the most electrophilic complex of its family. Acidolysis of the methyl groups of 4 is also facile. Most notably, 4 is thermally unstable in solution and undergoes isomerization via nitrosyl N-O bond cleavage to its oxo(imido) form, Cp*Mo(NMe)(O)Me (11), which is isolable from the final reaction mixture as the mu-oxo-bridged adduct formed by 4 and 11, i.e., Cp*Mo(NO)Me(2)(mu-O)Cp*Mo(NMe)Me (4 <-- 11). The rate of this isomerization is significantly faster for the tungsten dimethyl complex; hence, Cp*W(NO)Me(2) (12) is not isolable free of a supporting donor interaction and can only be isolated as Cp*W(NO)Me(2)(mu-O)Cp*W(NMe)Me (12 <-- 13) or Cp*W(NO)Me(2)(PMe(3)) (14) adducts.